Nisa Investment Advisors
AMRX icon

Nisa Investment Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Nisa Investment Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.6K Buy
6,803
+264
+4% +$3.54K ﹤0.01% 1489
2025
Q4 		$82.4K Sell
6,539
-400
-6% -$4.58K ﹤0.01% 1491
2025
Q3 		$69.5K Hold
6,939
– – ﹤0.01% 1537
2025
Q2 		$56.1K Sell
6,939
-357
-5% -$2.69K ﹤0.01% 1558
2025
Q1 		$61.1K Buy
7,296
+39
+0.5% +$326 ﹤0.01% 1544
2024
Q4 		$57.5K Buy
7,257
+188
+3% +$1.58K ﹤0.01% 1647
2024
Q3 		$58.8K Sell
7,069
-221,848
-97% -$1.73M ﹤0.01% 1604
2024
Q2 		$1.45M Buy
228,917
+222,144
+3,280% +$1.41M 0.01% 780
2024
Q1 		$41K Buy
6,773
+73
+1% +$412 ﹤0.01% 1703
2023
Q4 		$40.7K Hold
6,700
– – ﹤0.01% 1687
2023
Q3 		$28.3K Hold
6,700
– – ﹤0.01% 1903
2023
Q2 		$20.8K Buy
6,700
+5,180
+341% +$11K ﹤0.01% 2089
2023
Q1 		$2K Hold
1,520
– – ﹤0.01% 2310
2022
Q4 		$3K Hold
1,520
– – ﹤0.01% 2326
2022
Q3 		$3K Hold
1,520
– – ﹤0.01% 2332
2022
Q2 		$5K Hold
1,520
– – ﹤0.01% 2265
2022
Q1 		$6K Sell
1,520
-630
-29% -$2.79K ﹤0.01% 2275
2021
Q4 		$10K Hold
2,150
– – ﹤0.01% 2025
2021
Q3 		$11 Hold
2,150
– – ﹤0.01% 2190
2021
Q2 		$11 Sell
2,150
-17,900
-89% -$102K ﹤0.01% 2213
2021
Q1 		$135 Hold
20,050
– – ﹤0.01% 1625
2020
Q4 		$92K Buy
20,050
+1,150
+6% +$5.1K ﹤0.01% 1766
2020
Q3 		$73K Hold
18,900
– – ﹤0.01% 1649
2020
Q2 		$90K Sell
18,900
-11,800
-38% -$48.6K ﹤0.01% 1466
2020
Q1 		$107K Buy
30,700
+30,375
+9,346% +$129K ﹤0.01% 1351
2019
Q4 		$2K Sell
325
-39,120
-99% -$136K ﹤0.01% 1987
2019
Q3 		$114K Buy
39,445
+39,120
+12,037% +$136K ﹤0.01% 1431
2019
Q2 		$2K Hold
325
– – ﹤0.01% 1971
2019
Q1 		$5K Sell
325
-15,382
-98% -$203K ﹤0.01% 1897
2018
Q4 		$213K Hold
15,707
– – ﹤0.01% 1225
2018
Q3 		$349K Buy
15,707
+15,382
+4,733% +$324K ﹤0.01% 1196
2018
Q2 		$5K Buy
+325
New +$5.7K ﹤0.01% 1829

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Nisa Investment Advisors's AMRX Position: Q1 2026 in Review

Nisa Investment Advisors increased its Amneal Pharmaceuticals (AMRX) stake by 4% in Q1 2026, buying an estimated $3.54K and bringing the position to 6,803 shares worth $84.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

Nisa Investment Advisors first reported a position in AMRX in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.45M in Q2 2024. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Nisa Investment Advisors held 6,803 shares of Amneal Pharmaceuticals worth $84.6K as of Q1 2026.
  • Nisa Investment Advisors bought 264 Amneal Pharmaceuticals shares in Q1 2026, an estimated $3.54K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1489 holding.
  • Nisa Investment Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 32 quarters since.
  • Nisa Investment Advisors's Amneal Pharmaceuticals position peaked at $1.45M in Q2 2024.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.